Updated Jul 16, 2026
Sandercock Brett has filed 1 SEC Form 4 filing across 1 company in the last 90 days — selling. Lifetime open-market sales: $5.18M.
Brett Sandercock is the Chief Financial Officer of ResMed Inc., a leading global company in respiratory care devices. He has been involved in various SEC filings related to his role, indicating his active participation in the company's financial management.
| Role | Chief Financial Officer |
|---|---|
| Notability | 30/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-04-03 | RMD | RESMED INC | S — Open-market sale [10b5-1] | 1.0K | $224.31 | $224K |
| 2026-03-03 | RMD | RESMED INC | S — Open-market sale [10b5-1] | 1.0K | $254.30 | $254K |
| 2026-02-03 | RMD | RESMED INC | S — Open-market sale [10b5-1] | 1.0K | $257.03 | $257K |
| 2026-01-05 | RMD | RESMED INC | S — Open-market sale [10b5-1] | 1.0K | $241.75 | $242K |
| 2025-10-01 | RMD | RESMED INC | S — Open-market sale | 3.0K | $274.36 | $823K |
| 2025-10-01 | RMD | RESMED INC | M — Option exercise | 2.0K | $101.64 | $203K |
| 2025-09-02 | RMD | RESMED INC | S — Open-market sale | 3.0K | $270.77 | $812K |
| 2025-09-02 | RMD | RESMED INC | M — Option exercise | 2.0K | $101.64 | $203K |
| 2025-08-15 | RMD | RESMED INC | A — Grant or award | 5.5K | $0.00 | |
| 2025-08-01 | RMD | RESMED INC | S — Open-market sale | 3.0K | $281.90 | $846K |
| 2025-08-01 | RMD | RESMED INC | M — Option exercise | 2.0K | $101.64 | $203K |
| 2025-07-01 | RMD | RESMED INC | S — Open-market sale | 3.9K | $256.99 | $998K |
| 2025-07-01 | RMD | RESMED INC | M — Option exercise | 917 | $101.64 | $93K |
| 2025-07-01 | RMD | RESMED INC | M — Option exercise | 2.0K | $101.64 | $200K |
| 2024-12-11 | RMD | RESMED INC | S — Open-market sale [10b5-1] | 1.0K | $244.23 | $244K |
| 2024-11-12 | RMD | RESMED INC | S — Open-market sale [10b5-1] | 1.0K | $249.00 | $249K |
| 2024-10-09 | RMD | RESMED INC | S — Open-market sale [10b5-1] | 1.0K | $233.47 | $233K |
Brett Sandercock is the Chief Financial Officer of ResMed Inc., a leading global company in respiratory care devices. He has been involved in various SEC filings related to his role, indicating his active participation in the company's financial management.…
1 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 11 open-market sales ($5.18M) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Sandercock Brett profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.